Clinical Trials Directory

Trials / Terminated

TerminatedNCT04004156

Safety Study for An Artificial Disc Nucleus Replacement to Treat Chronic Low Back Pain

Safety Study for An Artificial Disc Replacement "PerQdisc Nucleus Replacement Device" NUCLEUS 181

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
9 (actual)
Sponsor
Spinal Stabilization Technologies · Industry
Sex
All
Age
22 Years – 60 Years
Healthy volunteers
Not accepted

Summary

This study will be a prospective, open-label, multi-center study that will collect safety data for the minimally invasive PerQdisc Nucleus Replacement Device deployed to reduce chronic low back pain.

Detailed description

This study will be a prospective, open-label, multi-center study that will collect safety data for the minimally invasive PerQdisc Nucleus Replacement Device (NRD). The NRD is used for surgical replacement of a single nucleus pulposus between spinal lumbar discs L1-S1 using an anterior or lateral transpsoas approach. Currently the surgical gold standard involves spinal fusion of the affected vertebral bodies, reducing range of motion and increasing stress on other vertebral bodies. The goal of nucleus replacement is to reduce chronic low back pain by maintaining disc height while preserving range of motion.

Conditions

Interventions

TypeNameDescription
DEVICEPerQdisc® Nucleus Replacement Device.All patients that meet the inclusion/exclusion criteria will receive the PerQdisc® Nucleus Replacement Device.

Timeline

Start date
2019-03-01
Primary completion
2022-03-17
Completion
2023-01-23
First posted
2019-07-01
Last updated
2025-05-21

Locations

4 sites across 4 countries: Belgium, Canada, Croatia, Germany

Source: ClinicalTrials.gov record NCT04004156. Inclusion in this directory is not an endorsement.